Impact of Covid-19 on gastrointestinal cancer surgery: A National Survey
Authors:
- 13 September 2022
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 407 (8) , 3735-3745
Abstract
Purpose To understand the actual impact of the Covid-19 pandemic and frame the future strategies, we conducted a pan India survey to study the impact on the surgical management of gastrointestinal cancers. Methods A national multicentre survey in the form of a questionnaire from 16 tertiary care gastrointestinal oncology centres across India was conducted from January 2019 to June 2021 that was divided into a 15-month pre-Covid era and a similar period of active Covid pandemic era. Results There was significant disruption of services; 13 (81%) centres worked as dedicated Covid care centres and 43% reported suspension of essential care for more than 6 months. In active Covid phase, there was a 14.5% decrease in registrations and proportion of decrease was highest in the centres from South zone (22%). There was decrease in resections across all organ systems; maximum reduction was noted in hepatic resections (33%) followed by oesophageal and gastric resections (31 and 25% respectively). There was minimal decrease in colorectal resections (5%). A total of 584 (7.1%) patients had either active Covid-19 infection or developed infection in the post-operative period or had recovered from Covid-19 infection. Only 3 (18%) centres reported higher morbidity, while the rest of the centres reported similar or lower morbidity rates when compared to pre-Covid phase; however, 6 (37%) centres reported slightly higher mortality in the active Covid phase. Conclusion Covid-19 pandemic resulted in significant reduction in new cancer registrations and elective gastrointestinal cancer surgeries. Perioperative morbidity remained similar despite 7.1% perioperative Covid 19 exposure.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Management of hepatocellular carcinoma in the time of COVID-19Annals of Oncology, 2020
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York CityAnnals of Oncology, 2020
- Cancer Management in India during Covid-19New England Journal of Medicine, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- How Coronavirus Disease 2019 Outbreak Is Impacting Colorectal Cancer Patients in Italy: A Long Shadow Beyond InfectionDiseases of the Colon & Rectum, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- [Surgical treatment strategy for digestive system malignancies during the outbreak of novel coronavirus pneumonia].2020
- The COVID-19 pandemic and the Tata Memorial Centre responseIndian Journal of Cancer, 2020
- The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016The Lancet Oncology, 2018
- Operative Microwave Ablation for Hepatocellular Carcinoma: Complications, Recurrence, and Long-Term OutcomesJournal of Gastrointestinal Surgery, 2013